Results 211 to 220 of about 36,599 (239)

CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway

, 2018
Xuejian Liu, Xia Wu, Yanming Wang, Yuhua Li, Xiangli Chen, Wenchuan Yang, Lihua Jiang   +6 more
openalex   +1 more source

m⁶A-modified CTC-297N7.9 inhibits hepatocellular carcinoma metastasis via epigenetically downregulating CCL2 and CD47. [PDF]

Cancer Cell Int
Wei H, Pu C, Zeng M, Lu R, Wei Y, Huang Y, Huang Z, Huang L, Xu Z, Wang J, Ma R, Pu J.   +11 more
europepmc   +1 more source

Novel CD47: SIRPα Dependent Mechanism for the Activation of STAT3 in Antigen-Presenting Cell

, 2013
Toledano Natan, Devorah Gur‐Wahnon, Ben-Yehuda Adi, Jacob Rachmilewitz   +3 more
openalex   +2 more sources

New power in cancer immunotherapy: the rise of chimeric antigen receptor macrophage (CAR-M). [PDF]

J Transl Med
Jing J, Chen Y, Chi E, Li S, He Y, Wang B, Shen H, Fan L, Wang J, Shangguan T, Ge X, Jiang Y, Chen Y, Xu C.   +13 more
europepmc   +1 more source

CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD. [PDF]

Front Endocrinol (Lausanne)
Jiang X, Zhao W, Shen B, Han Y, Chen K.
europepmc   +1 more source

An anti-CD47 antibody binds to a distinct epitope in a novel metal ion-dependent manner to minimize cross-linking of red blood cells. [PDF]

J Biol Chem
Lu X, Chen Z, Yi C, Ling Z, Ye J, Chen K, Cong Y, Sonam W, Cheng S, Wang R, Zhang D, Xu J, Yang J, Ma L, Duan Q, Sun X, Ding J, Sun B.   +17 more
europepmc   +1 more source

Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathway. [PDF]

Front Immunol
Kang T, Feng Z, Cai Y, Huang R, Wang R, Liu Z, Lu S, Xie S, Liu H, Chen S.   +9 more
europepmc   +1 more source

Localized Delivery of the mRNAs Encoding CD47 Inhibitor and Interleukins 12, 15, and 21 Elicits Robust Antitumor Immunity. [PDF]

Adv Sci (Weinh)
Jiang T, Jing S, Li H, Xiao B, Jin J, Sun X, Wang J, Liang J, Cai T, Hu H, Wei M, Zhong X, Ji Y, Wang PG, Zhou J.   +14 more
europepmc   +1 more source

Nano-therapeutics targeting the macrophage-based microenvironment in the treatment of atherosclerosis. [PDF]

J Transl Med
Xu Y, Zhang Y, Yu W.
europepmc   +1 more source

The impact of immune checkpoint inhibition on atherosclerosis in cancer patients. [PDF]

Front Immunol
Han R, Wang SH, Tian J, Zhou S.
europepmc   +1 more source